DocSym
β
Searchsearch
Search
(E16.9) Disorder of pancreatic internal secretion, unspecified
More details coming soon
971 353 in individuals diagnosis disorder of pancreatic internal secretion, unspecified confirmed
11 016 deaths with diagnosis disorder of pancreatic internal secretion, unspecified
1% mortality rate associated with the disease disorder of pancreatic internal secretion, unspecified
Diagnosis disorder of pancreatic internal secretion, unspecified is diagnosed Women are 10.75% more likely than Men
433 457
Men receive the diagnosis disorder of pancreatic internal secretion, unspecified
4 515 (1.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
537 896
Women receive the diagnosis disorder of pancreatic internal secretion, unspecified
6 501 (1.2 %)Died from this diagnosis.
Risk Group for the Disease disorder of pancreatic internal secretion, unspecified - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features disorder of pancreatic internal secretion, unspecified
Absence or low individual and public risk
Disorder of pancreatic internal secretion, unspecified - what does this mean
Disorder of pancreatic internal secretion, unspecified is a disorder that occurs when the pancreas does not produce enough of the hormones and enzymes needed to digest food or regulate blood sugar levels. it can be caused by genetic factors, certain medications, or diseases such as diabetes. symptoms may include abdominal pain, weight loss, nausea, and diarrhea. treatment may include dietary changes, medications, and lifestyle modifications to manage symptoms.
What happens during the disease - disorder of pancreatic internal secretion, unspecified
The pathogenesis of this disorder is likely due to a disruption in the normal functioning of the pancreatic cells that produce and secrete hormones such as insulin and glucagon. this disruption can be caused by a variety of factors including genetic mutations, environmental factors, or autoimmune diseases. when these hormones are not produced or secreted in the correct amounts, it can lead to a cascade of metabolic and endocrine disorders as well as an inability to properly regulate blood sugar levels.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Stool tests
- Imaging tests (CT scan, MRI, ultrasound, etc.)
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Endoscopic Ultrasound (EUS)
- Liver Function Tests (LFTs)
- Hormone tests
- Genetic testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of the disorder of pancreatic internal secretion, unspecified.
- Regular monitoring of blood sugar levels
- Elimination of foods high in fat and sugar from the diet
- Regular exercise
- Management of stress levels
- Regular monitoring of pancreatic enzymes
- Regular monitoring of vitamin and mineral levels
- Regular monitoring of electrolyte levels
- Regular monitoring of liver function
- Medication to control blood sugar levels
- Medication to stimulate pancreatic secretion
- Medication to reduce inflammation in the pancreas
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Disorder of pancreatic internal secretion, unspecified - Prevention
The best way to prevent disorder of pancreatic internal secretion, unspecified is to maintain a healthy lifestyle. this includes eating a balanced diet, getting regular exercise, avoiding smoking and excessive alcohol consumption, and managing stress. additionally, regular medical checkups can help detect any early signs of the disorder and lead to timely treatment.